| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 05/10/2005 | US6890924 Substituted bicyclic derivatives for the treatment of abnormal cell growth |
| 05/10/2005 | US6890915 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE) |
| 05/10/2005 | CA2278290C Quinazolinone compounds |
| 05/06/2005 | WO2005040345A2 4-azole substituted imidazole compositions useful as inhibitors or c-met receptor tyrosine kinase |
| 05/06/2005 | WO2005040154A1 Novel imidazole derivatives and their use as pharmaceutical agents |
| 05/06/2005 | WO2005040152A1 Heteroyclylphenyl-and heterocyclylpyridyl-substituted azolecarboxamides as herbicides |
| 05/06/2005 | WO2005040144A1 Novel compounds |
| 05/06/2005 | WO2005040131A1 1,5,7-trisubstituted benzimidazole derivatives and their use for modulating the gabaa receptor complex |
| 05/06/2005 | WO2005040116A2 Indolinone derivatives and their use in treating disease-states such as cancer |
| 05/06/2005 | WO2005040114A1 Compounds having crth2 antagonist activity |
| 05/06/2005 | WO2005040112A1 Compounds with pgd2 antagonist activity |
| 05/06/2005 | WO2005040110A1 Pyrrole and pyrazole derivatives as potentiators of glutamate receptors |
| 05/06/2005 | WO2005040109A1 Ligands of melanocortin receptors and compositions and methods related thereto |
| 05/06/2005 | WO2005039569A1 5-substituted 2-(phenylmethyl) thio-4-phenyl-4h-1,2,4-triazole derivatives and related compounds as gaba-agonists for the treatment of urinary incontinence and related diseases |
| 05/06/2005 | WO2005039564A1 Phthalimide compounds useful as protein kinase inhibitors |
| 05/06/2005 | WO2005005395A3 Arylamine-substituted quinazolinone compounds |
| 05/06/2005 | CA2542716A1 Compounds having crth2 antagonist activity |
| 05/06/2005 | CA2542682A1 5-substituted 2-(phenylmethyl) thio-4-phenyl-4h-1,2,4-triazole derivatives and related compounds as gaba-agonists for the treatment of urinary incontinence and related diseases |
| 05/06/2005 | CA2541460A1 Indolinone derivatives and their use in treating disease-states such as cancer |
| 05/06/2005 | CA2539726A1 4-azole substituted imidazole compositions useful as inhibitors or c-met receptor tyrosine kinase |
| 05/06/2005 | CA2538134A1 Novel imidazole derivatives and their use as pharmaceutical agents |
| 05/05/2005 | US20050096468 Inhibitors of histone deacetylase |
| 05/05/2005 | US20050096382 Agent for preventing recurrence of cerebrovascular disorder and agent for ameliorating troubles following cerebrovascular disorder and inhibiting progress thereof |
| 05/05/2005 | US20050096377 Substituted sulfonamide-indoles |
| 05/05/2005 | US20050096376 Such as (4-propyl-phenyl)-{3-[1-(4-trifluoromethyl-benzyl)-1H-indol-3-yl]-pyrrolidin-1-yl}-methanone; treatment of pain and/or depression |
| 05/05/2005 | US20050096368 Heterocyclo-substituted imidazoles for the treatment of inflammation |
| 05/05/2005 | US20050096363 Activator of peroxisome proliferator-activated receptor delta |
| 05/05/2005 | US20050096357 Antibiotics; therapy for infections which is caused by drug-resistant Streptococcus, or bacteria infections |
| 05/05/2005 | US20050096353 Indolyl and dihydroindolyl derivatives, their manufacture and use as pharmaceutical agents |
| 05/05/2005 | US20050096348 non-insulin dependent diabetes mellitus, and impaired glucose tolerance; dipeptidyl peptidase IV (DPP-IV) inhibitors eg (2S)-1-{[(1S)-2-(5-cyano-2-methyl-indol-1-yl)-1-methyl-ethylamino]-acetyl}-pyrrolidine-2-carbonitrile |
| 05/05/2005 | US20050096330 N-(indolecarbonyl) piperazine derivatives |
| 05/05/2005 | US20050096327 eg 2-(4-Methyl-piperazin-1-yl)-4-phenyl-quinazoline; attention deficit hyperactivity disorder |
| 05/05/2005 | US20050096309 For use as anticoagulant agents for therapy of thromboembolic disorders |
| 05/05/2005 | US20050096308 Antibacterial agents |
| 05/04/2005 | EP1528061A1 Heterocyclic derivatives which inhibit factor Xa |
| 05/04/2005 | EP1527067A1 4-trifluoromethylpyrazolyl substituted pyridines and pyrimidines |
| 05/04/2005 | EP1527053A1 Process for preparing rizatriptan |
| 05/04/2005 | EP1527051A1 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
| 05/04/2005 | EP1527046A1 Indoline derivatives substituted in position 6, production and use thereof as medicaments |
| 05/04/2005 | EP1448553B1 N-heterocyclyl hydrazides as neurotrophic agents |
| 05/04/2005 | EP1442022A4 Polyamide modulators of cox2 transcription |
| 05/04/2005 | EP1411881B1 5ht2c receptor modulators |
| 05/04/2005 | EP1317448B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/04/2005 | EP1119567B1 Quinazoline derivatives |
| 05/04/2005 | CN1612866A Amorphous and crystalline forms of losartan potassium and process for their preparation |
| 05/04/2005 | CN1612865A Triazole derivatives as cyclooxygenase (COX) inhibitors |
| 05/04/2005 | CN1612864A Novel alkansulfonamides as endothelin antagonists |
| 05/04/2005 | CN1612763A Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
| 05/04/2005 | CN1199969C New process |
| 05/04/2005 | CN1199954C Benzodiazepine derivatives |
| 05/03/2005 | US6888033 Contacting picornavirus with 2,6-dihydroxy acetophenone or its salt to inhibit replication of picornavirus |
| 05/03/2005 | US6888004 Imidazolyl derivatives as corticotropin releasing factor inhibitors |
| 05/03/2005 | US6887892 Tricyclic derivatives of indole with antiangiogenic activity |
| 05/03/2005 | US6887887 Asymmetric synthesis of (S,S,R)-(-)-actinonin and its analogs and uses therefor |
| 05/03/2005 | US6887875 2,5-diarypyrimidine compounds |
| 05/03/2005 | US6887874 For producing an antiangiogenic and/or vascular permeability reducing effect in a warm-blooded animal; therapy of cancer, rheumatoid arthritis |
| 05/03/2005 | US6887870 Useful as antianginal and cardioprotective agents; for therapy and prophylaxis of angina pectoris, cardiac dysfunction, myocardial necrosis, and arrhythmia |
| 05/03/2005 | US6887865 N-heterocyclic derivatives as NOS inhibitors |
| 05/03/2005 | US6887864 Anticancer agents, a benzoylamino-azepan-3-yl-isonicotinamide compounds |
| 05/03/2005 | CA2297486C 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1h-indole derivatives interacting with the dopamine d4 receptor |
| 05/03/2005 | CA2201477C New pyrimidone derivatives with antifungal activity |
| 04/28/2005 | WO2005037834A1 NOVEL TETRAYDROSPIRO{PIPERIDINE-2,7’ -PYRROLO[3,2-b]PYRIDINE DERIVATIVES AND NOVEL INDOLE DERIVATIVES USEFUL IN THE TREATMENT OF 5-HT6 RECEPTOR -RELATED DISORDERS |
| 04/28/2005 | WO2005037826A1 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases |
| 04/28/2005 | WO2005037823A1 Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1h-imidazole-1-yl)methyl]-4h-carbazol-4-one or its salt |
| 04/28/2005 | WO2005037822A1 Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1h-imidazole-1-yl)methyl]-4h-carbazol-4-one or its salt |
| 04/28/2005 | WO2005037821A2 Preparation of candesartan cilexetil |
| 04/28/2005 | WO2005037797A1 Substituted pyrazole urea compounds for the treatment of inflammation |
| 04/28/2005 | WO2005037796A1 Compounds and methods for treating dyslipidemia |
| 04/28/2005 | WO2005037792A1 Derivatives of n-``phenyl(piperidine-2-yl) methyl benzamide, preparation method thereof and applications of same in therapeutics |
| 04/28/2005 | WO2005037271A2 Large conductance calcium-activated k channel opener |
| 04/28/2005 | WO2005037199A2 Pyrazole derivatives as cannabinoid receptor modulators |
| 04/28/2005 | WO2005021495A3 Quaternary salt derivatives of 1,4-diphenylazetidin-2-ones |
| 04/28/2005 | WO2005019168A3 Fluorinated lysine derivatives as dipeptidyl peptidase iv inhibitors |
| 04/28/2005 | WO2004093817A3 Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 04/28/2005 | WO2004079434A3 Vapor deposited electro-optic films self-assembled through hydrogen bonding |
| 04/28/2005 | WO2004014844A3 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 04/28/2005 | US20050090672 Intermediates for production of losartan; chloroformylation; hydroxylation; angiotensin II antagonists; hypertension |
| 04/28/2005 | US20050090671 for human telomeres/telomerases; drug screening |
| 04/28/2005 | US20050090667 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof |
| 04/28/2005 | US20050090541 Indolinone derivatives and their use in treating disease-states such as cancer |
| 04/28/2005 | US20050090523 2-(substituted phenyl)imidazo[1,2-a]pyridine compounds; use to treat disorders mediated by the histamine H3 receptor such as sleep disorders, attention deficit hyperactivity disorder, or Alzheimer's disease; 2-[4-[3-(Piperidino)propylamino]phenyl]-8-methylimidazo[1,2-a]pyridine for example |
| 04/28/2005 | US20050090515 anticarcinogenic, antitumor, antiproliferative agents; focal adhesion kinase (FAK) and cyclin-dependent kinase (CDK) enzyme inhibitors |
| 04/28/2005 | US20050090503 5-HT receptor ligands and uses thereof |
| 04/28/2005 | US20050090495 Receptor binding assay using radiolabeled interleukin inhibitors; antiinflammatory agents for eosinophil-dependent inflammatory diseases |
| 04/28/2005 | US20050090493 Useful as anti-cancer agents; exhibit apoptotic effect in a warm-blooded animal such as man; for example, 2-{4-[3-(N,N-Dimethyl)amino-2-hydroxy-propoxy]anilino}-4-(2,4-difluoro-(N-cyanomethyl)anilino)pyrimidine |
| 04/28/2005 | US20050090486 Trisubstituted pyrimidines |
| 04/28/2005 | US20050090485 7-Arylsulfonamido-2,3,4,5-tetrahydro-1h-benzo'diazepine derivatives with 5ht6 receptor affinity for the reatment of cns disorders |
| 04/28/2005 | US20050090471 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto |
| 04/28/2005 | US20050090450 enzyme inhibitors such as Pyrazine-2-carboxylic acid (cyclohexyl-{1-[2-(1-cyclopropylaminooxalyl-butylcarbamoyl)-3-isopropyl-pyrrolidine-1-carbonyl]-2,2-dimethyl-propylcarbamoyl}-methyl)-amide, used for treating viral diseases or pretreatment of medical equipment |
| 04/28/2005 | US20050090398 Aryl ketone derivatives containing tetrazole moieties such as 5-cyclopropyl-4-{2,4-dichloro-3-[(1H-tetrazol-1-yl)methyl]benzoyl}isoxazole; good effect as a selective herbicide for paddy rice |
| 04/28/2005 | CA2542499A1 Preparation of candesartan cilexetil |
| 04/28/2005 | CA2542373A1 Derivatives of n-phenyl(piperidine-2-yl)methyl benzamide, preparation method thereof and applications of same in therapeutics |
| 04/28/2005 | CA2541509A1 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases |
| 04/28/2005 | CA2540861A1 Novel tetraydrospiro{piperidine-2,7' -pyrrolo[3,2-b]pyridine derivatives and novel indole derivatives useful in the treatment of 5-ht6 receptor -related disorders |
| 04/28/2005 | CA2539755A1 Alkanol and cycloalkanol-amine derivatives and methods of their use |
| 04/27/2005 | EP1525266A1 Site-specific labelling of proteins using cyanine dye reporters |
| 04/27/2005 | EP1525265A2 Chiral indole intermediates and their fluorescent cyanine dyes containing functional groups |
| 04/27/2005 | EP1525198A2 Acyloxypyrrolidine derivatives, preparation and therapeutic use thereof |
| 04/27/2005 | EP1525190A1 Cck-1 receptor modulators |
| 04/27/2005 | EP1524974A2 Transcription factor modulating compounds and methods of use thereof |